Institute: INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA

Research group: NEUROBIOQUÍMICA

Email: laugarvi@usal.es

Doctor by the Universidad de Salamanca with the thesis The anti-tumor peptide tat-cx43(266-283) modulates the interplay between glioblastoma cells and tumor-associated astrocytes 2022. Supervised by Dr. María Aránzazu Tabernero Urbieta.